Functional effects of striatal dysfunction in Parkinson disease

Archives of Neurology

Volumn 54, Issue 2, 1997, Pages 145-150

  Holthoff Detto, Vjera A ^a   Kessler, Josef ^a   Herholz, Karl ^a   Bönner, Hans ^a   Pietrzyk, Uwe ^a   Würker, Michael ^a   Ghaemi, Morad ^a   Wienhard, Klaus ^a   Heiss, Wanger Wolf Dieter ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMNESIA; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; HUMAN; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031041607     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550140025008     Document Type: Article

References (40)

1. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357-381.
2. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13:266-271.
3. Alexander GE, Crutcher MD, Delong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog Brain Res, 1990;85:119-146.
4. Gerfen CR. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 1992;15:133-139.
5. Brown RG, Marsden CD. Neuropschology and cognitive function in Parkinson's disease: an overview. In: Marsden CD, Fahn S, eds. Movement Disorders 2. London, England: Butterworths & Co Ltd; 1987:99-123.
6. Gibb WRG, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol. 1989;15:27-44.
7. Bernheimer M, Birkmeyer W, Hornykiewicz O, et al. Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci. 1973;20:415-445.
8. Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement Disorders 2. London, England: Butterworths & Co Ltd; 1987:166-230.
9. 18F]fluoro-3,4-dihydroxyphenylalanine in primate. J Neurochem. 1987;48:1077-1082.
10. Garnett ES, Firnau G, Nahmias C. Dopamine visualised in the basal ganglia of living man. Nature. 1983;305:137-138.
11. Playford ED, Brooks DJ. In vivo and in vitro studies of the dopaminergic system in movement disorders. Cerebrovasc Brain Metab Rev. 1992;4:144-171.
12. Stern Y. The basal ganglia and intellectual function. In: Schneider J, ed. Basal Ganglia and Behavior: Sensory Aspects of Motor Functioning. Toronto, Ontario: Hans Huber; 1987:169-174.
13. Brown RG, Marsden CD. Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci. 1990;13:21-28.
14. Raskin SA, Borod JC, Tweedy J. Neuropsychological aspects of Parkinson's disease. Neuropsychol Rev. 1990;1:185-221.
15. Dubois B, Boller F, Pillon B, Agid Y. Cognitive deficits in Parkinson's disease. In: Boller R, Grafman J, eds. Handbook of Neuropsychology, V. Amsterdam, the Netherlands: Elsevier Science Publishers; 1991:195-240.
16. Weingartner H, Burns S, Diebel R, LeWitt PA. Cognitive impairments in Parkinson's disease: distinguishing between effort-demanding and automatic cognitive processes. Psychiatry Res. 1984;11:223-235.
17. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
18. Schaaf A, Kessler J, Grond M, Fink GR. Der Memo-Test (nach der Methode des selektiven Erinnerns). Weinheim, Germany: Beitz-Test-Verlag; 1992.
19. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press Inc; 1991.
20. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
21. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
22. Wienhard K, Ericsson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr. 1992;16:804-813.
23. 18F]-2-fluoro-2-deoxy-D-glucose; a critical appraisal of optimization procedures. J Cereb Blood Flow Metab. 1985;5:115-125.
24. Bergström M, Eriksson L, Bohm C, Blomqvist G, Litton J. Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections. J Comput Assist Tomogr. 1983;7:42-50.
25. Pietrzyk U, Herholz K, Heiss WD. Three-dimensional alignment of functional and morphological tomograms. J Comput Assist Tomogr. 1990;14:51-59.
26. Stuss DT, Benson DF. The Frontal Lobes. New York, NY: Raven Press; 1986.
27. Fuster JM, The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. New York, NY: Raven Press; 1989.
28. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data: generalizations. J Cereb Blood Flow Metab, 1985;5:584-590.
29. Brooks DJ, Salmon EP, Mathias CJ, et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure anatomic failure, and Parkinson's disease, studied with PET. Brain. 1990;113:1539-1552.
30. 18F]fluoro-L-dopa in Parkinson's disease measured with positron emission tomography. Acta Neural Scand. 1990;81:24-30.
31. Mesulam MM. Principles of Behavioral Neurology. Philadelphia, Pa: FA Davis Co Publishers; 1985.
32. Brooks DJ, Frackowiak RSJ. PET and movement disorders. J Neurol Neurosurg Psychiatry. 1989;52(suppl):68-77.
33. Stern Y, Richards M, Sano M, Mayeux R. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Arch Neurol. 1993;50:1040-1045.
34. Dubois B, Danze F, Pillon B, Cusimano G, Lhermitte F, Agid Y. Cholinergic-dependent cognitive deficits in Parkinson's disease. Ann Neurol. 1987;22:26-30.
35. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain. 1991;114:2095-2122.
36. Holthoff VA, Vieregge P, Kessler J, et al. Discordant twins with Parkinson's disease; PET and early signs of impaired cognitive circuits. Ann Neurol. 1994;36:176-192.
37. Stern Y, Langston J. Intellectual changes in patients with MPTP-induced parkinsonian syndrome. Neurology. 1985;35:1506-1509.
38. Mayberg HS, Starkstein SE, Sadzot B, et al. Selective hypometabolism in the Inferior frontal lobe in depressed patients with Parkinson's disease. Ann Neurol. 1990;28:57-64.
39. 18F]fluorodeoxyglucose method. Ann Neurol. 1984;15:419-424.
40. Lloyd KG, Hornykiewicz O. Occurrence and distribution of aromatic add (L-dopa) decarboxylase in human brain. J Neurochem. 1972;19:1549-1559.